Fig. 2. Potential future applications of liquid or tissue biopsy-based molecular diagnostic tests in HCC.
cfDNA, cell-free DNA; CTCs, circulatory tumour cells; EVs, extracellular vesicles; HCC, hepatocellular carcinoma; MRD, minimal residual disease.